NCT04591483View on ClinicalTrials.gov

Stargardt-like Macular Dystrophy (STDG3) Secondary to Mutations in ELOVL4

RecruitingOBSERVATIONAL

Enrollment

25

Participants

Timeline

Start Date

April 19, 2022

Primary Completion Date

July 16, 2028

Study Completion Date

July 16, 2028

Conditions

Stargardt-Like Macular Dystrophy

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

National Eye Institute (NEI)

NIH